Vor Biopharma Inc. (VOR) Corporate Subsidiaries
Vor Biopharma Inc. (VOR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VOR
CIK: 1817229
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerMichael Mc Collister
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-02 | 4 Filing | 0001231919-26-001426 | View SEC Doc Filr Page |
| S-3ASR | 2026-09-04 | — | S-3ASR | 0001193125-26-383721 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | 4 Filing | 0001231919-26-001102 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000936 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000911 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0002088344-26-000009 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343607 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002253 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002174 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003175 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-21 | — | SCHEDULE 13D/A Filing | 0001346824-26-000197 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-16 | 4 Filing | 0001231919-26-000776 | View SEC Doc Filr Page |
| 3 | 2026-07-09 | 2026-07-07 | 3 | 0001193125-26-299666 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-07 | 4 | 0001193125-26-299665 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-06 | 8-K | 0001193125-26-297454 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001231919-26-000633 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-270002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-270000 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269999 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269998 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269997 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269996 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 | 0001193125-26-269994 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | 8-K | 0001193125-26-269431 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | 8-K | 0001193125-26-261661 | View SEC Doc Filr Page |